The Commonwealth Court has entered a more than $51 million bench verdict in favor of the Pennsylvania state government against pharmaceutical manufacturer Johnson & Johnson for allegedly overcharging state programs and consumers for prescription drug reimbursements.
On Dec. 7, Judge Robert Simpson filed a non-jury decision ordering the New Brunswick, N.J.-based drugmaker to reimburse the state government $45,283,562 and pay civil penalties in the amount of $6,567,000.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
